UPDATED Apr 22, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
MRE | CA$11.06 | 0.5% | -19.4% | CA$849.3m | CA$17.75 | PE5.5x | E22.0% | 1.8% | ||
ABCT | CA$6.73 | 0.6% | 43.8% | CA$778.5m | CA$6.75 | PB1.7x | S12.8% | 2.2% | ||
LAZR | US$1.30 | -2.3% | -76.5% | US$548.5m | US$4.96 | PS7.9x | E25.4% | n/a | ||
ECX | US$1.59 | 0.6% | -68.8% | US$537.5m | US$5.17 | PE-4.1x | E39.8% | n/a | ||
ABDP | UK£18.35 | 4.3% | 7.9% | UK£421.1m | UK£20.24 | PE38.3x | E-4.5% | 0.3% | ||
HSAI | US$4.04 | -1.7% | -52.4% | US$507.2m | US$11.04 | PS2x | E68.6% | n/a | ||
HLLY | US$4.18 | 0.7% | 90.9% | US$494.2m | US$7.47 | PE25.8x | E28.8% | n/a | ||
SRI | US$15.32 | -3.1% | -16.4% | US$422.1m | US$25.25 | PB1.5x | E112.3% | n/a | ||
FDOC | US$0.27 | 0% | 242.5% | US$376.1m | n/a | n/a | n/a | n/a | ||
GGR | US$1.46 | -4.3% | -55.1% | US$356.8m | US$3.50 | PS1x | E43.1% | n/a | ||
SLDP | US$1.66 | 3.8% | -26.9% | US$299.3m | US$3.63 | PS17.2x | E-1.9% | n/a | ||
CPS | US$15.51 | 0.3% | 41.6% | US$268.2m | US$22.00 | PE-1.3x | E78.4% | n/a | ||
RLEA | US$5.80 | 0% | n/a | US$238.4m | n/a | PS23.9x | n/a | n/a | ||
GOEV | US$3.40 | 16.0% | -80.3% | US$219.0m | US$12.86 | PS247.1x | E41.1% | n/a | ||
KNDI | US$2.50 | 12.6% | -12.3% | US$218.4m | n/a | PE30621.9x | n/a | n/a | ||
XTC | CA$7.07 | -1.3% | 1.3% | CA$274.1m | CA$13.00 | PE10x | S6.4% | 5.9% | ||
MAMO | US$4.33 | 14.9% | n/a | US$178.8m | n/a | PE17.2x | n/a | n/a | ||
SFC | AU$19.50 | -2.5% | 6.0% | AU$267.9m | n/a | PE15.3x | n/a | 4.6% | ||
NIU | US$2.06 | -5.5% | -43.9% | US$159.7m | US$2.93 | PB1.1x | E127.1% | n/a | ||
SUP | US$3.75 | 3.0% | -22.2% | US$108.5m | US$7.75 | PE-0.8x | E106.0% | 0% | ||
MPAA | US$5.50 | 1.5% | 25.0% | US$108.1m | US$14.00 | PB0.4x | E95.9% | n/a | ||
CAAS | US$3.52 | 1.2% | -20.0% | US$106.3m | n/a | PE2.8x | n/a | n/a | ||
STRT | US$21.91 | -4.4% | 10.7% | US$89.1m | US$29.00 | PE385.8x | E193.1% | 0% | ||
EQIP | UK£0.058 | 0% | -34.3% | UK£57.4m | n/a | PS9.5x | E65.2% | n/a |